![Dale Zajicek](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Historial de carrera de Dale Zajicek
Antiguos cargos conocidos de Dale Zajicek.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ONCOLIX, INC. | Director/Miembro de la Junta | 01/09/2017 | 06/03/2019 |
Independent Dir/Board Member | 01/09/2017 | 06/03/2019 | |
BioVectra, Inc.
![]() BioVectra, Inc. Pharmaceuticals: MajorHealth Technology BioVectra, Inc. manufactures and supplies custom active pharmaceutical ingredients to the North American and European markets. It offers specialty and fine chemicals, advanced intermediates, enzymes and biomolecules, as well as provide custom synthesis and manufacturing services for the pharmaceutical, biopharmaceutical, and nutraceutical industries. The company was founded by Regis J. Duffy in 1970 and is headquartered in Charlottetown, Canada. | Director de Operaciones | 01/01/2005 | - |
Presidente | - | 01/01/2015 | |
Oncolix, Inc. /Old/
![]() Oncolix, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Oncolix, Inc. engages in the development and manufacture of biopharmaceutical products for the treatment of breast cancer. It offers Prolanta, a targeted therapeutic protein for the treatment of ovarian and breast cancer. The company was founded in November 2006 and is headquartered in Houston, TX. | Director/Miembro de la Junta | - | - |
Independent Dir/Board Member | 04/10/2017 | - |
Formación de Dale Zajicek.
Illinois Institute of Technology | Undergraduate Degree |
Elmhurst College | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 5 |
Canadá | 2 |
Operativa
Director/Board Member | 2 |
Independent Dir/Board Member | 2 |
Undergraduate Degree | 2 |
Sectorial
Health Technology | 4 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 3 |
---|---|
BioVectra, Inc.
![]() BioVectra, Inc. Pharmaceuticals: MajorHealth Technology BioVectra, Inc. manufactures and supplies custom active pharmaceutical ingredients to the North American and European markets. It offers specialty and fine chemicals, advanced intermediates, enzymes and biomolecules, as well as provide custom synthesis and manufacturing services for the pharmaceutical, biopharmaceutical, and nutraceutical industries. The company was founded by Regis J. Duffy in 1970 and is headquartered in Charlottetown, Canada. | Health Technology |
Oncolix, Inc. /Old/
![]() Oncolix, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Oncolix, Inc. engages in the development and manufacture of biopharmaceutical products for the treatment of breast cancer. It offers Prolanta, a targeted therapeutic protein for the treatment of ovarian and breast cancer. The company was founded in November 2006 and is headquartered in Houston, TX. | Health Technology |
Oncolix, Inc.
![]() Oncolix, Inc. Pharmaceuticals: MajorHealth Technology Oncolix, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of medical therapies for the treatment of various cancers including ovarian, breast, uterine, and prostate. Its brand Prolanta is a drug designed to block the effect of human prolactin in cancers, either as a stand-alone therapy or in combination with other drugs, by blocking the effect of human prolactin. The company was founded on June 2013 and is headquartered in Houston, TX. | Health Technology |
- Bolsa de valores
- Insiders
- Dale Zajicek
- Experiencia